Prestige BioPharma950210 
$10.181.12%24h
1.12%24h
Global rank10247
Market cap$608.99M
Change 7d3.21%
YTD Performance41.36%
SP500 benchmarkOutperform
P/E0.03
P/S4991.64
Revenue$122.00K
Earnings-$2.16M
Dividend yield-
EPS for Prestige BioPharma (950210)
Prestige BioPharma has an EPS of $293.6. In 2022, the company made an earnings per share (EPS) of $-3519.2. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 950210
-
Value:-
EPS history for Prestige BioPharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $293.60 | -108.34% |
| 2022 | -$3.52K | 2357.54% |
| 2021 | -$143.20 | -59.27% |
| 2020 | -$351.60 | - |
View the highest EPS stocks
